Found: 16
Select item for more details and to access through your institution.
The cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The cannabinoid CB<sub>2</sub> receptor agonist AM1241 enhances neurogenesis in GFAP/ Gp120 transgenic mice displaying deficits in neurogenesis.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 2, p. 468, doi. 10.1111/bph.12478
- By:
- Publication type:
- Article
Effects of Cannabinoid Agonists and Antagonists in Rats Discriminating Fentanyl.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R4829
- By:
- Publication type:
- Article
Biochemical and Proteomic Characterization of Recombinant Human α/β Hydrolase Domain 6.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-36633-4
- By:
- Publication type:
- Article
Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.
- Published in:
- Brain & Behavior, 2012, v. 2, n. 2, p. 155, doi. 10.1002/brb3.44
- By:
- Publication type:
- Article
Role of the endogenous cannabinoid system in nicotine addiction: novel insights.
- Published in:
- Frontiers in Psychiatry, 2015, v. 6, p. 1, doi. 10.3389/fpsyt.2015.00041
- By:
- Publication type:
- Article
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029900
- By:
- Publication type:
- Article
Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.575691
- By:
- Publication type:
- Article
Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist.
- Published in:
- British Journal of Pharmacology, 2004, v. 142, n. 3, p. 495, doi. 10.1038/sj.bjp.0705792
- By:
- Publication type:
- Article
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.
- Published in:
- Molecular Pain, 2014, v. 10, n. 1, p. 1, doi. 10.1186/1744-8069-10-27
- By:
- Publication type:
- Article
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.
- Published in:
- Molecular Pain, 2014, v. 10, n. 1, p. 1, doi. 10.1186/1744-8069-10-27
- By:
- Publication type:
- Article
Antinociceptive Effects of Racemic AM1241 and Its Chirally Synthesized Enantiomers: Lack of Dependence upon Opioid Receptor Activation.
- Published in:
- AAPS Journal, 2010, v. 12, n. 2, p. 147, doi. 10.1208/s12248-009-9170-8
- By:
- Publication type:
- Article
Differentiation between low- and high-efficacy CB receptor agonists using a drug discrimination protocol for rats.
- Published in:
- Psychopharmacology, 2014, v. 231, n. 3, p. 489, doi. 10.1007/s00213-013-3257-8
- By:
- Publication type:
- Article
AM2389, a high-affinity, in vivo potent CB-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice.
- Published in:
- Psychopharmacology, 2012, v. 220, n. 2, p. 417, doi. 10.1007/s00213-011-2491-1
- By:
- Publication type:
- Article
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB receptor antagonist rimonabant in rats.
- Published in:
- Psychopharmacology, 2011, v. 216, n. 3, p. 355, doi. 10.1007/s00213-011-2226-3
- By:
- Publication type:
- Article